Market Newsdesk

LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the “Company”), an influencer-based marketing and media firm with a global aggregate social media reach of over 100 million followers, is pleased to report that, effective January 20, 2021, its corporate name has changed to Clubhouse Media Group, Inc. (from Tongji Healthcare Group, Inc.), and its stock symbol has changed to CMGR (from TONJ).

“As an emerging leader in the influencer-based social media marketing space, with extensive commercial interests and growing cash flows, we are now manifestly active under a business model that has no relationship to the Company’s prior name and stock symbol,” remarked Chris Young, Co-Founder of Clubhouse Media. “This shift, while superficial, is significant in that it will allow us to present a more cohesive picture to the investment community, which we believe will ultimately play a substantive role in delivering shareholder value.”

The Company’s prior corporate name and stock symbol were tied to a former operational model in the healthcare space. However, since acquiring Clubhouse Media Group in August 2020, the Company has undergone a wholesale management and business model change. Over recent months, as the Clubhouse Media influencer team has expanded its reach to over 100 million followers across multiple social media platforms, the Company has also generated extensive coverage in traditional media under its new identity.

Given these advances, management believed the Company’s prior market identity no longer reflected a coherent picture. The new corporate name and stock symbol will create a far more internally coherent narrative platform as the Company develops deeper relationships with new partners, clients, stakeholders, and customers, as well as with the wider investment community.

About Clubhouse Media

We believe Clubhouse Media represents the future of influencer media and marketing, with a global network of professionally run content houses, each of which has its own brand, influencer cohort and production capabilities. Clubhouse Media offers management, production and deal-making services to its handpicked influencers, a management division for individual influencer clients, and an investment arm for joint ventures and acquisitions for companies in the social media influencer space. Clubhouse Media’s management team consists of successful entrepreneurs with financial, legal, marketing, and digital content creation expertise.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Media Contact

Natalie Yallouz // [email protected]
Emily Merkley // [email protected]
Kim Gutierrez // [email protected]

Corporate Contact
Simon Yu, MBA
Phone: +1-702-479-3016

Investor Relations
Tiger Marketing & Branding Agency
[email protected]

Wire Service Contact

InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
[email protected]

CAMBRIDGE, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,889,587, which is directed to a crystalline formulation of tebipenem HBr, Spero’s oral carbapenem in development for the treatment of complicated urinary tract infection (cUTI) and acute pyelonephritis (AP). In September 2020, Spero announced positive top-line results from its Phase 3 ADAPT-PO clinical trial of tebipenem HBr in cUTI and AP.

The U.S. Patent No. 10,889,587 covers a crystalline form and pharmaceutical compositions of tebipenem HBr, including the methods of manufacturing and methods of use. The patent expires in February 2038.

“This patent issuance by the USPTO is an important milestone in protecting the commercial potential of tebipenem HBr and is a sign of Spero’s innovation while developing the drug as the first oral carbapenem, if approved,” said Ankit Mahadevia, M.D., Chief Executive Officer of Spero Therapeutics. “We remain focused on advancing oral tebipenem HBr towards a potential approval and look forward to submitting the New Drug Application for tebipenem HBr to the FDA in the second half of 2021.”

Tebipenem HBr has been granted Qualified Infectious Disease Product (QIDP) status by the U.S. Food and Drug Administration (FDA), which provides for an additional five-year extension of Hatch-Waxman Act exclusivity. Tebipenem HBr has also been granted fast track status by the FDA.

About Tebipenem HBr

Tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994) is Spero’s novel investigational oral formulation of tebipenem pivoxil, a carbapenem antibiotic of the β-lactam class marketed by Meiji Seika Pharma Co. Ltd. (Meiji) in Japan as Orapenem® since 2009 for pediatric infections limited to pneumonia, otitis media and sinusitis. Orapenem® is not approved in the U.S. Carbapenems are an important subclass of antibiotics because they have been observed to be safe and effective in the treatment of drug-resistant Gram-negative bacterial infections. Tebipenem HBr is being developed for the treatment of cUTI and AP. In September 2020, Spero announced positive top-line results from its Phase 3 ADAPT-PO clinical trial of tebipenem HBr in cUTI and AP. Spero expects to submit a New Drug Application to the U.S. Food and Drug Administration (FDA) for tebipenem HBr in the second half of 2021. If approved, tebipenem HBr would be the first oral carbapenem to receive marketing approval in the United States.

About Spero Therapeutics

Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.

Spero’s lead product candidate, tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994), is being developed as the first oral carbapenem antibiotic for use in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP).

Spero is also advancing SPR720, its novel oral therapy product candidate being developed for the treatment of rare, orphan pulmonary disease caused by non-tuberculous mycobacterial (NTM) infections.

Spero also has an IV-administered next generation polymyxin product candidate, SPR206, developed from its potentiator platform that is being developed to treat MDR Gram-negative infections in the hospital setting.

For more information, visit https://sperotherapeutics.com.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements include, but are not limited to, statements about the initiation, timing and submission to the FDA of a NDA for tebipenem HBr, the potential approval of tebipenem HBr by the FDA and commercialization of tebipenem HBr and the potential therapeutic and other benefits of Spero’s product candidates. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intent,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including Spero’s ability to timely complete related Phase 1 trials for its planned NDA submission for tebipenem HBr, taking into account the possible effects of the COVID-19 pandemic; Spero’s need for additional funding; the lengthy, expensive, and uncertain process of clinical drug development; whether results obtained in preclinical studies and clinical trials will be indicative of results obtained in future clinical trials; Spero’s reliance on third parties to manufacture, develop, and commercialize its product candidates, if approved; the ability to develop and commercialize Spero’s product candidates, if approved; the potential impact of the COVID-19 pandemic; Spero’s ability to retain key personnel and to manage its growth; Spero’s ability to maintain and enforce its intellectual property; whether Spero’s cash resources will be sufficient to fund its continuing operations for the periods and/or trials anticipated; and other factors discussed in the “Risk Factors” set forth in filings that Spero periodically makes with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent Spero’s views as of the date of this press release. Spero anticipates that subsequent events and developments will cause its views to change. However, while Spero may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Spero’s views as of any date subsequent to the date of this press release.

Spero Investor and Media Contact:

Sharon Klahre
Vice President, Investor Relations
857-242-1547
[email protected]

CORNELIUS, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) — Aquesta Financial Holdings, Inc and subsidiaries (“Aquesta”) (OTC Market symbol AQFH) – including its subsidiary Aquesta Bank announced today net income for the fourth quarter of 2020 (three month period ending December 31, 2020). For the fourth quarter of 2020, Aquesta had unaudited net income of $1.9 million (34 cents per share) compared to fourth quarter of 2019 net income of $1.1 million (20 cents per share). For the twelve months ended December 31, 2020 net income was $5.3 million (96 cents per share) compared to the twelve months ended December 31, 2019 of $4.4 million (82 cents per share). Thus, earnings grew at 20.9 percent in 2020 compared to 2019.

Jim Engel, CEO and President of Aquesta, said “I am proud to announce excellent earnings and balance sheet growth for the final quarter of 2020 which caps another year of strong performance here at Aquesta. Despite the uncertainty caused by the COVID-19 pandemic, Aquesta has succeeded in providing the highest levels of service and value to our customers, communities and shareholders. As we turn the page on 2020, Aquesta looks to maintain our upward momentum and excellent performance into 2021 and beyond.”

Key Highlights

• Total loan growth of $139.9 million for the twelve months ended December 31, 2020 or 33.7 percent. Loan growth was primarily due to PPP loans as Aquesta focused resources on helping our communities. The increase in total loan portfolio size related to these PPP loans is expected to be temporary and will decrease as the PPP loans are forgiven and/or paid down. However, organic loan growth was strong in 2020 as the net increase in non-PPP loans was $26.5 million, or 6.4 percent, compared to December 31, 2019.
• Total core deposit growth of $120.8 million for the twelve months ended December 31, 2020 or 32.3 percent. Core deposit growth was due to the large number of new deposit customers brought to Aquesta by PPP loans and organic growth.
• Earnings growth for the twelve months ended December 31, 2020 compared to the twelve months ended December 31, 2019 of $910 thousand or 20.9 percent.
• During the fourth quarter of 2020, paid the eighth annual consecutive cash dividend to shareholders. Adjusted for stock splits, the cash dividend has increased every year.

Solid Balance Sheet Growth

At December 31, 2020, Aquesta’s total assets were $680.2 million compared to $523.0 million at December 31, 2019. Total loans were $555.0 million at December 31, 2020 compared to $415.1 million at December 31, 2019. 2020 loan growth was primarily driven by PPP loans, which totaled $113.4 million as of December 31, 2020. However, organic loan growth was strong in 2020 as the net increase in non-PPP loans was $26.5 million, or 6.4 percent, compared to December 31, 2019. Core deposits were $494.3 million at December 31, 2020 compared to $373.6 million at December 31, 2019.

Asset Quality

Nonperforming assets were at $6.1 million as of December 31, 2020 compared to $1.2 million as of December 31, 2019. Aquesta had $5.7 million in non-accrual loans as of December 31, 2020 compared to $1.2 million as of December 31, 2019. The increase of both nonperforming assets and non-accrual loans is primarily related to a small concentration of customers. Aquesta held Other Real Estate Owned (i.e., “OREO” or foreclosed property) of $382 thousand at the end of the 4^th quarter 2020 compared to none at end of the 4^th quarter 2019.

Net Interest Income

Net interest income was $19.8 million for the twelve months ended December 31, 2020 compared to $16.6 million for the twelve months ended December 31, 2019. This is an increase of $3.2 million or 19.1%. The increase in net interest income is associated with an increased reliance on lower cost core deposits replacing higher cost funding. Additionally, Aquesta was able to accrete $2.1 million of PPP fees into interest income for PPP loans that were held throughout 2020. Aquesta deferred an additional $2.1 million of PPP fee income which will be recognized in subsequent quarters as PPP loans are forgiven or paid down.

Provision for Loan Losses

The provision for loan losses was $2.0 million for the twelve months ended December 31, 2020 compared to $340 thousand for the twelve months ended December 31, 2019. This is an increase of $1.6 million. The increase is due to the ongoing COVID-19 pandemic and management’s estimation of potential losses in the loan portfolio.

The ratio of ALLL to total loans is 0.96% as of December 31, 2020. The ratio of ALLL to total loans, excluding PPP loans, is 1.20% as of December 31, 2020. The ratio of ALLL to total loans, excluding PPP loans and balances guaranteed by the SBA, is 1.38% as of December 31, 2020.

Non Interest Income

Non interest income was $2.9 million for the twelve months ended December 31, 2020 compared to $2.8 million for the twelve months ended December 31, 2019.

Non Interest Expense

Non interest expense was $13.9 million for the twelve months ended December 31, 2020 compared to $13.7 million for the twelve months ended December 31, 2019.

Personnel expense was at $7.7 million as of December 31, 2020 compared to $8.5 million as of December 31, 2019. The decrease in personnel expense is due to the offsetting of salary related costs with PPP origination fees pursuant to ASC 310-20 stemming from the closing and funding of PPP loans.

Occupancy expense increased by $152 thousand for the twelve months ended December 31, 2020 compared to the twelve months ending December 31, 2019. The increase is due to the addition of the Rae Farms branch and the adoption of new lease accounting standards which required the recognition of additional lease expense in 2020.

Aquesta had gain on the sale of OREO of $13 thousand for the twelve months ended December 31, 2020 compared to gain on sale of $18 thousand for the twelve months ended December 31, 2019.

Below are the financial highlights for comparison:

Aquesta Financial Holdings, Inc.
Select Financial Highlights
(Dollars in thousands, except per share data)
		12/31/20				12/31/19
		(unaudited)				(audited)
Period End Balance Sheet Data:
Loans	$	554,950			$	415,071
Allowance for loan and lease losses		5,319				3,868
Investment securities		52,559				56,688
Total assets		680,168				523,010
Core deposits		494,346				373,557
CDs and IRAs		63,623				46,413
Shareholders equity		58,542				53,367
Ending shares outstanding*		5,473,205				5,450,585
Book value per share*		10.70				9.79
Tangible book value per share*		10.69				9.79
*assumes conversion of Series A Convertible Perpetual Preferred Stock
		For the three months ended								For the twelve months ended
		12/31/20				12/31/19				12/31/20				12/31/19
		(unaudited)				(audited)				(unaudited)				(audited)
Income and Per Share Data:
Interest income	$	6,901			$	5,789			$	24,308			$	22,562
Interest expense		916				1,462				4,529				5,957
Net interest income		5,985				4,327				19,779				16,605
Provision for loan losses		444				(25	)			1,952				340
Net interest income after
provision for loan losses		5,541				4,352				17,827				16,265
Non interest income		1,079				1,118				2,851				2,847
Non interest expense		4,226				4,172				13,918				13,730
Income before income taxes		2,394				1,298				6,760				5,382
Income tax expense		543				204				1,497				1,029
Net Income		1,851				1,094				5,263				4,353

		For the three months ended								For the twelve months ended
		12/31/20				12/31/19				12/31/20				12/31/19
		(unaudited)				(audited)				(unaudited)				(audited)
Earnings per share – basic*	$	0.34			$	0.20			$	0.96			$	0.82
Earnings per share – diluted*		0.32				0.19				0.91				0.77
Weighted average shares – basic*		5,472,837				5,437,259				5,470,697				5,302,640
Weighted average shares – diluted*		5,769,434				5,763,633				5,772,519				5,630,070
* assumes conversion of Series A Convertible Perpetual Preferred Stock
		12/31/20				12/31/19
		(unaudited)				(audited)
Select performance ratios:
Return on average assets		0.87	%			0.89	%
Return on average equity		9.41	%			10.03	%
Asset quality data:
90 days or more and accruing	$	40			$	–
Non accrual loans		5,655				1,192
Other real estate owned		382				–
Total non performing assets		6,077				1,192
Troubled debt restructurings	$	54			$	84
Non performing assets / total assets		0.89	%			0.23	%
Allowance for loan losses / total loans		0.96	%			0.93	%

Aquesta Financial Holdings, Inc. is the holding company to its wholly owned subsidiary, Aquesta Bank. Aquesta Bank is a full-service community bank headquartered in Cornelius, North Carolina with eight branches in the Charlotte, Lake Norman and Wilmington, North Carolina areas and loan production offices in Raleigh, North Carolina, as well as Greenville and Charleston, South Carolina.

For additional information, please contact Kristin Couch (Executive Vice President and Chief Financial Officer) at 704-439-4343 or visit us online at www.aquesta.com.

Information in this press release may contain forward looking statements that might involve risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include without limitation, the effects of future economic conditions, governmental fiscal and monetary policies, legislative and regulatory changes, and changes in interest rates.

RICHMOND, Va., Jan. 21, 2021 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), the global leader in total cash management, route-based secure logistics and payment solutions, today announced that it expects fourth-quarter 2020 revenue of approximately $1.02 billion. Fourth-quarter 2020 operating profit is expected to exceed the high end of the company’s October 29 guidance range (GAAP $64 million to $79 million; non-GAAP $104 million to $119 million). 

Doug Pertz, president and chief executive officer, said: “Our preliminary fourth-quarter non-GAAP results reflect continued revenue recovery and margin rate expansion, driven by sustainable cost reductions. While we continue to operate in a challenging near-term environment due to the persistence of the pandemic, we are very encouraged by these results. We expect continued margin expansion in 2021 and look forward to providing our initial outlook for next year when we release final 2020 results on February 23, which will include a change in segment reporting related primarily to the incorporation of our G4S cash operations.”

Brink’s will release final 2020 results prior to hosting a conference call on Tuesday, February 23, at 8:30 a.m. (ET). Results will reflect four geographic segments including North America (U.S. & Canada), Latin America (including Mexico), Europe and Rest of World. Comparable historical data under the new segment reporting structure will also be disclosed. Previously, Brink’s reported results from three geographic segments– North America, South America and Rest of World.

The conference call can be accessed by calling 888-349-0094 (in the U.S.) or 412-902-0124 (international). Participants should call in at least five minutes prior to the start of the call. Participants can pre-register at https://dpregister.com/sreg/10151538/e1068759fa to receive a direct dial-in number for the call. The call also will be accessible via live webcast at https://services.choruscall.com/links/bco210223.html.

A replay of the call will be available through March 23, 2021, at (877) 344-7529 (in the U.S.) or (412) 317-0088 (international). The conference number is 10151538. A webcast replay will also be available at www.investors.brinks.com.

Non-GAAP Results Reconciled to GAAP (Unaudited)

(In millions)

Non-GAAP results described in this press release are financial measures that are not required by or presented in accordance with U.S. generally accepted accounting principles (“GAAP”). The purpose of the Non-GAAP results is to report financial information from the primary operations of our business by excluding the effects of certain income and expenses that do not reflect the ordinary earnings of our operations. The Non-GAAP financial measures are intended to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. Additionally, Non-GAAP results are utilized as performance measures in certain management incentive compensation plans.

			Fourth Quarter 2020 GAAP Outlook (b)		Reconciling Items (a)		Fourth Quarter 2020 Non-GAAP Outlook (a)
	Operating Profit		$ 64 – 79		40		104 -119

a)	The 2020 Non-GAAP outlook amounts provided on October 29, 2020 excluded certain forecasted Non-GAAP adjusting items, such as intangible asset amortization and U.S. retirement plan costs. We had not forecasted the impact of highly inflationary accounting on our Argentina operations in 2020 or other potential Non-GAAP adjusting items for which the timing and amounts were under review as of October 29, 2020, such as restructuring actions. The 2020 Non-GAAP outlook amounts for operating profit could not be reconciled to GAAP without unreasonable effort as of October 29, 2020.  We could not reconcile this amount to GAAP because we were unable to accurately forecast the impact of highly inflationary accounting on our Argentina operations in 2020 or other potential Non-GAAP adjusting items for which the timing and amounts were under review as of October 29, 2020, such as restructuring actions.
b)	The 2020 GAAP outlook provided on October 29, 2020 excluded any forecasted impact from highly inflationary accounting on our Argentina operations as well as other potential Non-GAAP adjusting items for which the timing and amounts were under review as of October 29, 2020, such as restructuring actions.

About The Brink’s Company
The Brink’s Company (NYSE:BCO) is the global leader in total cash management, route-based secure logistics and payment solutions including cash-in-transit, ATM services, cash management services (including vault outsourcing, money processing and intelligent safe services), and international transportation of valuables. Our customers include financial institutions, retailers, government agencies, mints, jewelers and other commercial operations. Our global network of operations in 52 countries serves customers in more than 100 countries. For more information, please visit our website at www.brinks.com or call 804-289-9709.

Preliminary Financial Results Fourth Quarter 2020

The preliminary financial results for the fourth quarter ended December 31, 2020, included in this press release represent the most current information available to management and have not been audited. Actual results may differ from these preliminary results due to the completion of the company’s financial closing procedures, final adjustments, completion of the review by the company’s independent registered public accounting firm and other developments that may arise between the date of this press release and the time that financial results for the fourth quarter ended December 31, 2020 are finalized.

Forward-Looking Statements

This release contains forward-looking information. Words such as “anticipate,” “assume,” “estimate,” “expect,” “target” “project,” “predict,” “intend,” “plan,” “believe,” “potential,” “may,” “should” and similar expressions may identify forward-looking information. Forward-looking information in this release includes, but is not limited to, 2020 fourth quarter revenue and operating profit. Forward-looking information in this release is subject to known and unknown risks, uncertainties and contingencies, which are difficult to predict or quantify, and which could cause actual results, performance or achievements to differ materially from those that are anticipated.

Forward-looking information in this release is subject to known and unknown risks, uncertainties and contingencies, which are difficult to predict or quantify, and which could cause actual results, performance or achievements to differ materially from those that are anticipated. These risks, uncertainties and contingencies, many of which are beyond our control, include, but are not limited to: our ability to improve profitability and execute further cost and operational improvement and efficiencies in our core businesses; our ability to improve service levels and quality in our core businesses; market volatility and commodity price fluctuations; seasonality, pricing and other competitive industry factors; investment in information technology (“IT”) and its impact on revenue and profit growth; our ability to maintain an effective IT infrastructure and safeguard confidential information; our ability to effectively develop and implement solutions for our customers; risks associated with operating in foreign countries, including changing political, labor and economic conditions, regulatory issues (including the imposition of international sanctions, including by the U.S. government), currency restrictions and devaluations, restrictions on and cost of repatriating earnings and capital, impact on the Company’s financial results as a result of jurisdictions determined to be highly inflationary, and restrictive government actions, including nationalization; labor issues, including negotiations with organized labor and work stoppages; pandemics (including the ongoing COVID-19 pandemic and related impact to and restrictions on the actions of businesses and consumers, including suppliers and customers), acts of terrorism, strikes or other extraordinary events that negatively affect global or regional cash commerce; anticipated cash needs in light of our current liquidity position and the impact of COVID-19 on our liquidity; the strength of the U.S. dollar relative to foreign currencies and foreign currency exchange rates; our ability to identify, evaluate and complete acquisitions and other strategic transactions and to successfully integrate acquired companies; costs related to dispositions and product or market exits; our ability to obtain appropriate insurance coverage, positions taken by insurers relative to claims and the financial condition of insurers; safety and security performance and loss experience; employee and environmental liabilities in connection with former coal operations, including black lung claims; the impact of the Patient Protection and Affordable Care Act on legacy liabilities and ongoing operations; funding requirements, accounting treatment, and investment performance of our pension plans, the VEBA and other employee benefits; changes to estimated liabilities and assets in actuarial assumptions; the nature of hedging relationships and counterparty risk; access to the capital and credit markets; our ability to realize deferred tax assets; the outcome of pending and future claims, litigation, and administrative proceedings; public perception of our business, reputation and brand; changes in estimates and assumptions underlying critical accounting policies; the promulgation and adoption of new accounting standards, new government regulations and interpretation of existing standards and regulations.

This list of risks, uncertainties and contingencies is not intended to be exhaustive. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2019 and in our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020, and in our other public filings with the Securities and Exchange Commission. The forward-looking information included in this document is representative only as of the date of this document and The Brink’s Company undertakes no obligation to update any information contained in this document.

Contact:
Investor Relations
804.289.9709

ROCKAWAY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Health Improvement Scotland (“HIS”) has published a Scottish Health Technology Group (“SHTG”) adaptation for NHS Scotland on the use of gammaCore for cluster headache. The SHTG publication is based on guidance produced in 2019 by the U.K. National Institute for Health and Care Excellence (“NICE”), which states that gammaCore, when used alongside standard of care, can reduce the frequency and intensity of cluster headache attacks, leading to significant quality of life benefits for people living with this condition and can save an average of £450 per patient in the first year of treatment through a reduction in acute rescue medication use, and with electroCore offering no-cost evaluations for all patients. The SHTG publication recommends that gammaCore should be available for a 3-month trial period for use in treating NHS Scotland patients suffering from cluster headache and the SHTG adaptation will now be disseminated across NHS Scotland health boards by HIS, to inform the use of gammaCore for cluster headache.

“We are delighted by the recommendation from the Scottish Health Technology Group to consider the application of the medical technology guidance produced by NICE in 2019 to NHS Scotland,” said Iain Strickland, electroCore’s VP of European Operations. “We welcome the opportunity to provide our proven and established therapy to more patients in Scotland suffering from the debilitating condition of cluster headache. I would like to thank the Scottish experts who worked on this assessment and arrived at the conclusion that an equivalent recommendation to the one in effect in England and Wales was also needed in Scotland. The publication notes the devastating impact that cluster headaches can have on the lives of sufferers and the desperation that can result from ineffective treatment, so the further ratification of gammaCore as an effective treatment option is great to see.”

The SHTG adaptation can be viewed at:

http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/topics_assessed/adaptation_01-21.aspx

About Scottish Health Technology Group

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency. They provide evidence support and advice to NHS Scotland on the use of new and existing health technologies which are not medicines and which are likely to have significant implications for people’s care.

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

About gammaCore™
gammaCore™ (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. 

gammaCore is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients. gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache (Migraine, Cluster Headache, Trigeminal Autonomic Cephalalgias and Hemicrania Continua) and Medication Overuse Headache in adults.

• Safety and efficacy of gammaCore have not been evaluated in the following patients:
  • Patients diagnosed with narrowing of the arteries (carotid atherosclerosis)
  • Patients who have had surgery to cut the vagus nerve in the neck (cervical vagotomy)
  • Pediatric patients
  • Pregnant women
  • Patients with clinically significant hypertension, hypotension, bradycardia, or tachycardia
• Patients should not use gammaCore if they:
  • Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
  • Have a metallic device such as a stent, bone plate, or bone screw implanted at or near their neck
  • Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., mobile phone)

In the US, the FDA has not cleared gammaCore for the treatment of pneumonia and/or respiratory disorders such as acute respiratory stress disorder associated with COVID-19.

Please refer to the gammaCore Instructions for Use for all of the important warnings and precautions before using or prescribing this product.

Forward-Looking Statements

This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about anticipated government support provided by the HIS, SHTG, NHS and NICE; statements about electroCore’s business prospects and clinical and product development plans; its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments; the Company’s business prospects in Eastern Europe and other new markets and other statements that are not historical in nature, particularly those that utilize terminology such as “anticipates,” “will,” “expects,” “believes,” “intends,” other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to raise the additional funding needed to continue to pursue electroCore’s business and product development plans, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize gammaCore™, the potential impact and effects of COVID-19 on the business of electroCore, electroCore’s results of operations and financial performance, and any measures electroCore has and may take in response to COVID-19 and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov.

Investors:

Hans Vitzthum
LifeSci Advisors
617-430-7578
[email protected]

or

Media Contact:

Jackie Dorsky
electroCore
973-290-0097
[email protected]

BURLINGTON, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that it has installed a new cloud service center in Japan, with Toyota Motor Corporation (TMC) signing on as its first user. The new cloud center provides AI-powered innovation, products and technologies such as speech recognition, text-to-speech, and natural language understanding. With this new facility, Cerence delivers even faster response times, enabling a smoother experience for automakers and mobility OEMs that have deployed Cerence’s AI products in Japan.

Toyota, one of the pioneer users of cloud service from Cerence prior to its spin out, began leveraging the service in 2014 for cloud-based speech recognition technology for the Agent function of Toyota’s Connected Services. Agent is an interactive voice service that allows drivers to search and set destinations, check the weather, and search for other information. When drivers speak to Toyota’s Connected Services-compatible in-car navigation system, such as “Find a restaurant with a parking lot nearby,” the Agent searches for information and responds verbally, creating a natural, human-like exchange in the car. By now utilizing the cloud hosting site in Japan, the Agent’s response time will be improved, enabling Toyota to provide a smoother and more advanced driver experience to its connected service users in the future.

“As expectations for AI-powered automotive assistants continue to expand for Japanese drivers and around the world, we are committed to growing and enhancing our offerings to meet their needs,” said Shojiro Kimura, Regional Vice President, Japan, Cerence. “The installation of our new cloud service center in Japan demonstrates our constant dedication to bringing a state-of-the-art experience to our Japanese OEM customers like Toyota Motor Corporation and their drivers.”

To learn more about Cerence, visit www.cerence.com, and follow the company on LinkedIn and Twitter.

About Cerence Inc.

Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the world’s leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, powerful interaction between humans and their cars, two-wheelers, and even elevators, connecting consumers’ digital lives to their daily journeys no matter where they are. Cerence’s track record is built on more than 20 years of knowledge and more than 350 million cars shipped with Cerence technology. Whether it’s connected cars, autonomous driving, e-vehicles, or buildings, Cerence is mapping the road ahead. For more information, visit www.cerence.com.

Contact Information

Kate Hickman
Cerence Inc.
Tel: 339-215-4583
Email: [email protected]

NEWARK, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (Nasdaq: SSTI), a leader in precision policing solutions that enable law enforcement to more effectively respond to, investigate and deter crime, today launched a new program to help protect public officials and visitors to federal, state and local government campuses given the new threats that have emerged due to the recent assault on the U.S. Capitol and the heightened potential for violent armed conflict at government facilities across the country.

After the unprecedented violent events of January 6 in Washington D.C., the FBI and other intelligence sources have warned law enforcement agencies across the U.S. about potential threats to state capitols, city halls and other government buildings. “In response to these new threats, law enforcement is beefing up security at government buildings,” said Clark Ervin, former Inspector General of the U.S. Department of Homeland Security. “However, the government can’t maintain this heightened level of security across all locations after the high visibility events are over. That’s where solutions like acoustic gunshot detection can be better utilized to provide layered protection 24×7 throughout the year.”

To address this nationwide threat, ShotSpotter is launching a new program today based on its SecureCampus^® acoustic gunshot detection solution. SecureCampus leverages the same technology used in ShotSpotter Respond™, ShotSpotter’s award-winning acoustic gunshot detection solution for cities that is used in over 100 U.S. jurisdictions. ShotSpotter has already been protecting a number of University of California campuses and HBCUs (Historically Black Colleges and Universities) with SecureCampus. The solution is now being promoted to government facilities and campuses and their surrounding areas that need protection from the threat of outdoor gunfire. The new program includes dedicated security experts to customize solutions for maximum impact, simplified pricing bundles to make quotations faster, and professional services to integrate acoustic gunshot detection into existing video surveillance and access-control security infrastructure.

“We appear to be entering a new phase of increased domestic threats and ShotSpotter is here to help provide an important acoustic gunshot detection element to any layered security strategy enabling first responders to more quickly mitigate the threat and provide aid to victims,” said Ralph A. Clark, President and CEO of ShotSpotter. “With the launch of our new program for ShotSpotter’s SecureCampus, we can better protect high value government campuses and capitol locations along with the people who work, visit and congregate in the outdoor spaces around these locations.”

SecureCampus ensures private security and local law enforcement are alerted to gunshot incidents within seconds. Acoustic sensors placed high on surrounding buildings listen for loud, impulsive sounds that could be gunshots. Using a combination of machine learning and human review, incidents are quickly verified and alerts are sent to smartphones and computers including a precise location of the incident, number of rounds fired, and tactical information such as number of shooters or the use of automatic or high-capacity weapons. Security and law enforcement can use the alerts to quickly mobilize and safely eliminate the threat. A number of related technologies from other providers, such as cameras and access controls, can also be integrated to provide additional intelligence and security in real time.

About ShotSpotter

ShotSpotter (Nasdaq: SSTI) is a leader in precision policing solutions that enable law enforcement officials to more effectively respond to, investigate and deter crime. The company’s products are trusted by more than 100 U.S. cities to help make their communities safer. The platform includes its flagship product, ShotSpotter Respond™, the leading gunshot detection, location and forensic system, and ShotSpotter Connect™, patrol management software to dynamically direct patrol resources to areas of greatest risk and more effectively deter crime. ShotSpotter’s CrimeCenter™ investigative case management software helps detectives connect the dots and share information more effectively to improve case clearance rates. ShotSpotter also serves the government, corporate and college security markets and has been designated a Great Place to Work^® Company. 

For more media information for ShotSpotter, contact:

Media Contact:
Liz Einbinder 
ShotSpotter, Inc. 
+1 (510) 794-3147
[email protected]

Investor Relations Contacts:

Matt Glover
Gateway Investor Relations
+1 (949) 574-3860
[email protected]

JoAnn Horne
Market Street Partners
+1 (415) 445-3240
[email protected]

PALO ALTO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) —

• A seamless, single user-interface that delivers real-time AI insights from the Nauto Risk Reduction and Fleet Safety Platform and Geotab world-leading telematics products
• Integrated SSO solution can help fleets reduce risk and lower collision-related costs

Nauto®, the leading provider of artificial intelligence-powered driver and fleet safety products, today announced the availability of its Driver and Fleet Safety Platform on the Geotab Marketplace, a go-to source for top organizations seeking to better manage their fleets. The integration creates a seamless, single-sign-on (SSO) user-interface between Nauto’s Driver and Fleet Safety Platform and Geotab’s world-leading fleet management capabilities.

With Geotab’s award-winning telematics device and Nauto’s insights derived from nearly one billion AI-analyzed miles of driving data, fleet managers will be able to gain greater visibility and insights into their vehicles and drivers. These insights can be conveniently accessed through a single user-interface, eliminating the need to switch between several different platforms.

The Nauto and Geotab integration provides fleet and safety leaders with real-time access to video and data from Nauto’s multi-sensor device on the Geotab Marketplace to provide enhanced visibility and insight into the safety performance of each vehicle and driver. Together, Nauto and Geotab are delivering the ability to manage fleet resources more effectively, helping to achieve stronger compliance and reduce risk through machine learning algorithms that can aid in improving driver behavior before an incident occurs.

“Nauto is the first real-time, AI-powered Driver and Fleet Safety Platform to help predict, actively prevent, and reduce high-risk events in the mobility ecosystem,” said Stefan Heck, Nauto CEO and Founder. “This partnership will enable us to provide commercial fleets as well as the broader Geotab ecosystem with access to our AI-powered Driver and Fleet Safety Platform. This integration will help customers take their safety programs, productivity, and efficiency to the next level.”

Fleet Safety Leaders Collaborate
The Nauto Driver and Fleet Safety Platform is the first in-vehicle technology leveraging AI sensors and intervention to help make real-time decisions about imminent risks that can provide on average a 40% – 60% reduction in collision frequency and collision-related costs.¹ Nauto provides real-time alerting and feedback that does not require to be uploaded to the cloud for analysis and human review, providing immediate driver intervention at the first sign of unsafe behavior. 

Geotab offers best-in-class technology that connects commercial vehicles to the internet and provides web-based analytics to help customers better manage their fleets. With more than 2.1 million connected vehicles across the globe, Geotab is a proven leader in IoT and connected transportation and has been recognized as the world’s #1 Commercial Telematics Provider by ABI Research for two consecutive years. By processing over 40 billion data points a day, Geotab leverages data analytics and machine learning to provide customers with enhanced visibility into their drivers and vehicles.

“We are excited to welcome Nauto to the Geotab ecosystem,” said Louis De Jong, Executive Vice President, Geotab.” As safety is a core pillar at Geotab, we are always looking for ways to help our customers minimize risk and improve driver safety. With the addition of Nauto on the Marketplace, customers have access to a solution that can help reduce the likelihood of an at-fault accident from occurring and gain greater visibility into driver behavior.” 

About Geotab
Geotab is advancing security, connecting commercial vehicles to the internet, and providing web-based analytics to help customers better manage their fleets. Geotab’s open platform and Marketplace, offering hundreds of third-party solution options, allows both small and large businesses to automate operations by integrating vehicle data with their other data assets. As an IoT hub, the in-vehicle device provides additional functionality through IOX Add-Ons. Processing billions of data points a day, Geotab leverages data analytics and machine learning to help customers improve productivity, optimize fleets through the reduction of fuel consumption, enhance driver safety, and achieve strong compliance to regulatory changes. Geotab’s products are represented and sold worldwide through Authorized Geotab Resellers. To learn more, please visit www.geotab.com and follow us @GEOTAB and on LinkedIn.

About Nauto
Nauto® is the only real-time AI-powered Driver and Fleet Safety Platform able to help predict, prevent, and reduce high-risk events in the mobility ecosystem. By analyzing billions of data points from nearly one billion AI-analyzed video miles, Nauto’s machine learning algorithms continuously improve and help to impact driver behavior before events happen, not after. Nauto has enabled the largest commercial fleets in the world to avoid more than 45,000 collisions, resulting in nearly $260 million in savings. Nauto is located in North America, Japan, and Europe. Learn more at nauto.com or on LinkedIn, Facebook, Twitter, and YouTube.

¹ Nauto, Driver Safety Report: Reduce Distracted Driving with Real-Time In-Vehicle AI, 2019.

 

# # #

Public Relations
Nauto
[email protected]

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES

TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Bragg Gaming Group Inc. (TSX.V: BRAG, OTC: BRGGF) (“Bragg” or the “Company”) announced today that it has elected to exercise its right under the terms of a warrant indenture dated November 18, 2020 (the “Warrant Indenture”) governing the common share purchase warrants of the Company issued on November 18, 2020 (the “Warrants”) to accelerate the expiry date of the Warrants. 

Pursuant to the Warrant Indenture, the Company may accelerate the expiry of these Warrants at any time prior to 4:30pm (Toronto time) on November 18, 2023 in the event the daily volume weighted average trading price of the common shares of the Company (“Common Shares”) on the TSX Venture Exchange exceeds $1.50 for at least 10 consecutive trading days by providing written notice to the warrantholders (the “Acceleration Notice”). The Warrants will, unless exercised, expire on the 30th day after the Company provides the Acceleration Notice.

As of the close of markets on January 19, 2021, the volume weighted average trading price of the Common Shares had traded in excess of $1.50 for at least 10 consecutive trading days. Accordingly, Bragg has given notice to all registered warrant holders that the expiry date for the Warrants is accelerated to February 22, 2021.

As of January 20, 2021, a total of 14,516,702 Warrants have yet to be exercised. Each Warrant is exercisable to acquire one Common Share at an exercise price of $1.00. If all Warrants are exercised, proceeds to the Company will total $15,673,292.

About Bragg Gaming Group

Bragg Gaming Group Inc. (TSXV: BRAG, OTC: BRGGF) is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg’s main portfolio is ORYX Gaming, an innovative B2B gaming technology platform and casino content aggregator.

Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry. Learn more at https://www.bragg.games.

For Bragg Gaming Group, contact:
Yaniv Spielberg, CSO, Bragg Gaming Group
+1-647-800-2282
[email protected]

For media enquiries or interviews, please contact:
Lina Sennevall, Square in the Air 
[email protected]

For investor inquiries, please contact:

Tim Dawson, Bragg Gaming Group
+1-289-276-1167
[email protected]

For US investor inquiries, please contact:

Laine Yonker, Edison Group
+1-646-653-7035
[email protected]

Cautionary Statement Regarding Forward-Looking Information

This news release may contain forward-looking statements or “forward-looking information” within the meaning of applicable Canadian securities laws (“forward-looking statements”). Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements. The key assumptions that have been made in connection with the forward-looking statements include the following: the ability of the Company to obtain financing to pay the earn-out payment due on September 30, 2020; the impact of COVID-19 on the business of Bragg; the countercyclical growth of the business of Bragg; the regulatory regime governing the business of Bragg; the operations of the Company; the products and services of the Company; Bragg’s customers; acquisition opportunities; the growth of Bragg’s business, which may not be achieved or realized within the time frames stated or at all; and the anticipated size and/or revenue associated with the gaming market in the U.S. and globally.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the following: risks associated with general economic conditions; adverse industry events; future legislative and regulatory developments; the inability to access sufficient capital from internal and external sources; the inability to access sufficient capital on favorable terms; realization of growth estimates, income tax and regulatory matters; the ability of Bragg to implement its business strategies; competition; economic and financial conditions, including volatility in interest and exchange rates, commodity and equity prices; the estimated size of the gaming market in the U.S. and globally; changes in customer demand; disruptions to our technology network including computer systems and software; natural events such as severe weather, fires, floods and earthquakes; and risks related to health pandemics and the outbreak of communicable diseases, such as the current outbreak of COVID-19.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) (CSE:VS) (FRANKFURT:BMVB) today announced that it closed its previously-announced public offering of 1,280,000 units. Further, the underwriter has exercised in full its over-allotment option to purchase an additional 192,000 common shares, at the public offering price, less the underwriting discount. The offering was priced at USD $7.50 per unit, for gross proceeds of USD $11,040,000, before deducting underwriting discounts and commissions and other offering expenses payable by Versus. Each unit consists of one common share, one Unit A Warrant and one Unit B Warrant, each to purchase one common share at USD $7.50 per share.

The common shares and Unit A Warrants began trading on The Nasdaq Capital Market on January 15, 2021 under the ticker symbols “VS” and “VSSYW”, respectively.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (“SEC”) on January 14, 2021. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Lake Street Capital Markets, LLC acted as sole book-running manager for the offering.

This offering was made only by means of a prospectus. A copy of the final prospectus relating to this offering was filed with the SEC on January 19, 2021 and may also be obtained from the offices of Lake Street Capital Markets, LLC, 920 Second Avenue South, Suite 700, Minneapolis, Minnesota 55402, by telephone at (612) 326-1305, or by email at [email protected]. These documents may also be obtained free of charge, by visiting the SEC’s website at www.sec.gov.

The Company intends to use the net proceeds of this offering to repay indebtedness in the principal amount of USD $250,000 and the balance for working capital and general corporate purposes, including marketing and sales expenses, the costs and expenses of the continuing development of Versus’ prizing and rewards platform and salaries and wages.

About Versus Systems

Versus Systems Inc. has developed a proprietary in-game prizing and promotions engine that allows publishers, developers, and creators of games, apps, and other interactive media content to offer real world prizes inside their content. Players, viewers and users can choose from among the offered prizes and then complete in-game or in-app challenges to win the prizes. The Versus platform can be integrated into mobile, console, and PC games, as well as streaming media and mobile apps.

For Versus Systems, contact:

Matthew Pierce, Chief Executive Officer
[email protected]

Cody Slach, Sean McGowan
Gateway Investor Relations
949-574-3860
[email protected]
or
[email protected]